Genentech

Categories: News | Companies
    • Stock symbol: DNA (NYSE)
    • Annual revenue (2007): $2.9 billion
    • Founders: Robert A. Swanson, Herbert W. Boyer
    • Year established: 1976
    • Industry: Biotechnology
    • Phone: 650-225-1000
    • Fax: 650-225-6000+
    • Headquarters: South San Francisco, California
    • CEO: Dr. Arthur D. Levinson
    • CFO: David A. Ebersman
    • Staff (as of 2007): 10,560
  • Genentech is a company that pioneered biotechnology as both a science and a business. It was co-founded by Dr. Herbert W. Boyer, who helped develop DNA recombination technology. Genentech is a leading pharmaceutical developer and manufacturer, was the first to manufacture synthetic insulin.
  • Key Dates

    1. 1976: Founded by venture capitalist Robert A. Swanson and biochemist Herbert W. Boyer
    2. 1982: Synthesizes insulin, and distributes it through partnership with Eli Lilly and Company
    3. October 15, 2007: Science Magazine names it the Top Employer, Forbes names it Most Admired Biotech Company

About this page

  • Page Views
    0
What is this?
No one is currently managing this page.
What is this?
This page currently has no vertical manager.